John Chute
Director, Division of Hematology and Cellular Therapy · Cedars-Sinai Medical Center
Credentials: · · · ·
History
- Present
- 1996–1997
Hematology
- 1994–1996
- 1990–1993
Research
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Nature · 2009 · 702 citations
Proceedings of the National Academy of Sciences of the United States of America · 2006 · First of 7 authors · Corresponding · 361 citations
Systematic review or meta-analysis · Journal of Clinical Oncology · 1999 · First of 5 authors · 287 citations
43 papers
20 papers
19 papers
19 papers
19 papers
18 papers
- PD
15 papers · 5 as a fellow
13 papers · 5 as a fellow
Grants
- 2025–2027
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $334K · Cedars-Sinai Medical Center
- 2020–2025
Mitigation of Radiation Injury via Vascular Regeneration and Remodeling
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.6M · Cedars-Sinai Medical Center
- 2008–2023
Semaphorin Signaling Regulates Vascular and Hematopoietic Regeneration
National Heart, Lung, and Blood Institute · R01
Contact PI · $4.6M · Cedars-Sinai Medical Center
- 2005–2021
The UCLA Center for Medical Countermeasures Against Radiation
National Institute of Allergy and Infectious Diseases · U19
PI · $15.7M · University of California Los Angeles
Clinical trials
- 2024–2027
Sub-investigator · Recruiting · Phase 1
Joshua Sasine, MD, PhD
- 2023–2028
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
Sub-investigator · Recruiting · Phase 1
Ronald Paquette